258 related articles for article (PubMed ID: 12082543)
1. Mouse models of neurofibromatosis 1 and 2.
Gutmann DH; Giovannini M
Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
[TBL] [Abstract][Full Text] [Related]
2. Optimizing biologically targeted clinical trials for neurofibromatosis.
Gutmann DH; Blakeley JO; Korf BR; Packer RJ
Expert Opin Investig Drugs; 2013 Apr; 22(4):443-62. PubMed ID: 23425047
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.
Carroll SL
Acta Neuropathol; 2012 Mar; 123(3):321-48. PubMed ID: 22160322
[TBL] [Abstract][Full Text] [Related]
4. Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.
Vasudevan HN; Payne E; Delley CL; John Liu S; Mirchia K; Sale MJ; Lastella S; Nunez MS; Lucas CG; Eaton CD; Casey-Clyde T; Magill ST; Chen WC; Braunstein SE; Perry A; Jacques L; Reddy AT; Pekmezci M; Abate AR; McCormick F; Raleigh DR
Nat Commun; 2024 Jan; 15(1):477. PubMed ID: 38216572
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.
Blakeley JO; Plotkin SR
Neuro Oncol; 2016 May; 18(5):624-38. PubMed ID: 26851632
[TBL] [Abstract][Full Text] [Related]
6. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.
Giovannini M; Robanus-Maandag E; van der Valk M; Niwa-Kawakita M; Abramowski V; Goutebroze L; Woodruff JM; Berns A; Thomas G
Genes Dev; 2000 Jul; 14(13):1617-30. PubMed ID: 10887156
[TBL] [Abstract][Full Text] [Related]
7. Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2.
Kotch C; Brosius SN; De Raedt T; Fisher MJ
Pediatr Neurosurg; 2023; 58(5):267-280. PubMed ID: 36746138
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.
Bajenaru ML; Zhu Y; Hedrick NM; Donahoe J; Parada LF; Gutmann DH
Mol Cell Biol; 2002 Jul; 22(14):5100-13. PubMed ID: 12077339
[TBL] [Abstract][Full Text] [Related]
9. The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis.
Blakeley JO; Bakker A; Barker A; Clapp W; Ferner R; Fisher MJ; Giovannini M; Gutmann DH; Karajannis MA; Kissil JL; Legius E; Lloyd AC; Packer RJ; Ramesh V; Riccardi VM; Stevenson DA; Ullrich NJ; Upadhyaya M; Stemmer-Rachamimov A
Am J Med Genet A; 2017 Jun; 173(6):1714-1721. PubMed ID: 28436162
[TBL] [Abstract][Full Text] [Related]
10. Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.
Giovannini M; Robanus-Maandag E; Niwa-Kawakita M; van der Valk M; Woodruff JM; Goutebroze L; Mérel P; Berns A; Thomas G
Genes Dev; 1999 Apr; 13(8):978-86. PubMed ID: 10215625
[TBL] [Abstract][Full Text] [Related]
11. Mouse tumor model for neurofibromatosis type 1.
Vogel KS; Klesse LJ; Velasco-Miguel S; Meyers K; Rushing EJ; Parada LF
Science; 1999 Dec; 286(5447):2176-9. PubMed ID: 10591653
[TBL] [Abstract][Full Text] [Related]
12. Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner.
Walrath JC; Fox K; Truffer E; Gregory Alvord W; Quiñones OA; Reilly KM
Mamm Genome; 2009 Apr; 20(4):214-23. PubMed ID: 19347398
[TBL] [Abstract][Full Text] [Related]
13. Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study.
Wang KE; Vranceanu AM; Lester EG
PLoS One; 2023; 18(12):e0295546. PubMed ID: 38127915
[TBL] [Abstract][Full Text] [Related]
14. Update from the 2013 International Neurofibromatosis Conference.
Plotkin SR; Albers AC; Babovic-Vuksanovic D; Blakeley JO; Breakefield XO; Dunn CM; Evans DG; Fisher MJ; Friedman JM; Giovannini M; Gutmann DH; Kalamarides M; McClatchey AI; Messiaen L; Morrison H; Parkinson DB; Stemmer-Rachamimov AO; Van Raamsdonk CD; Riccardi VM; Rosser T; Schindeler A; Smith MJ; Stevenson DA; Ullrich NJ; van der Vaart T; Weiss B; Widemann BC; Zhu Y; Bakker AC; Lloyd AC
Am J Med Genet A; 2014 Dec; 164A(12):2969-78. PubMed ID: 25255738
[No Abstract] [Full Text] [Related]
15. Schwann cells modulate nociception in neurofibromatosis 1.
Raut NG; Maile LA; Oswalt LM; Mitxelena I; Adlakha A; Sprague KL; Rupert AR; Bokros L; Hofmann MC; Patritti-Cram J; Rizvi TA; Queme LF; Choi K; Ratner N; Jankowski MP
JCI Insight; 2024 Jan; 9(2):. PubMed ID: 38258905
[TBL] [Abstract][Full Text] [Related]
16. Generation of a zebrafish neurofibromatosis model via inducible knockout of
Rajan ARD; Huang Y; Stundl J; Chu K; Irodi A; Yang Z; Applegate BE; Bronner ME
bioRxiv; 2024 Apr; ():. PubMed ID: 38712289
[TBL] [Abstract][Full Text] [Related]
17. Hyperplasia of Arachnoid Trabecular Cells: A Hitherto Undescribed Lesion Observed in the Setting of Neurofibromatosis Type 1.
Maehara T; Yamazaki A; Kawabata-Iwakawa R; Fukuoka K; Akazawa A; Okura N; Nishiyama M; Nassiri F; Wang JZ; Zadeh G; Kikuta K; Oka H; Hirato J; Yokoo H; Nobusawa S
Am J Surg Pathol; 2023 Jul; 47(7):819-825. PubMed ID: 37226836
[TBL] [Abstract][Full Text] [Related]
18.
Atsoniou K; Giannopoulou E; Georganta EM; Skoulakis EMC
Cells; 2024 Apr; 13(8):. PubMed ID: 38667335
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.
McLean DT; Meudt JJ; Lopez Rivera LD; Schomberg DT; Pavelec DM; Duellman TT; Buehler DG; Schwartz PB; Graham M; Lee LM; Graff KD; Reichert JL; Bon-Durant SS; Konsitzke CM; Ronnekleiv-Kelly SM; Shanmuganayagam D; Rubinstein CD
Front Oncol; 2023; 13():1253659. PubMed ID: 37817770
[TBL] [Abstract][Full Text] [Related]
20. Cerebellum-dependent associative learning is not impaired in a mouse model of neurofibromatosis type 1.
Ottenhoff MJ; Dijkhuizen S; Ypelaar ACH; de Oude NL; Koekkoek SKE; Wang SS; De Zeeuw CI; Elgersma Y; Boele HJ
Sci Rep; 2022 Nov; 12(1):19041. PubMed ID: 36351971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
